Portland, OR, April 25, 2019 (GLOBE NEWSWIRE) -- According to a report published by Allied Market Research, the global apheresis market generated $2.75 billion in 2017 and is expected to garner $4.20 billion by 2023, registering a CAGR of 7.3% during the forecast period, 2017-2023.
Request Report Sample at: https://www.alliedmarketresearch.com/request-sample/2855
The growth of the global apheresis market is driven by rising demand for blood components across the globe, surge in government initiatives regarding blood donation, and recently approved indications for apheresis treatment. Additionally, the increase in demand for plasma-driven pharmaceuticals is set to provide lucrative opportunities for emerging market players in the near future. However, lack of skilled professionals and complications pertaining to apheresis procedure restrain the market growth.
By procedure, the donor/automated apheresis segment is expected to generate almost two-thirds of the global revenue by 2023, due to increase in gap between blood supply and blood products, which facilitate the need for using apheresis machines. However, the therapeutic apheresis segment is projected to register the highest CAGR of 8.3% from 2017 to 2023.
By method, the membrane separation segment is projected to grow at the fastest CAGR of 8.1% during the forecast period, due to the rise in demand for membrane separation apheresis as it prevents the need for replacement fluids by not depleting the blood coagulation factors. However, the centrifugation segment is expected to dominate the market and occupy more than two-fifths of the global market by 2023, as centrifugation is considered to be a standard method for apheresis and is highly favored by the blood industry across the globe.
Regionally, Asia-Pacific is projected to encounter the highest CAGR of 8.8% during the forecast period, on account of its high population base, upsurge in disposable income, and rise in patient awareness toward blood donation. Additionally, rise in prevalence of dengue outbreak across countries in the Asia-Pacific region would supplement future growth.
Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2855
The key players analyzed in the report include Haemonetics Corporation, Fresenius Kabi, Terumo BCT, Inc., Asahi Kasei Medical Co., Ltd., HemaCare Corporation, Kaneka Corporation, Kawasumi Laboratories Inc., Cerus Corporation, B. Braun Melsungen AG, and Nikkiso Co., Ltd. They have adopted different strategies including collaborations, joint ventures, partnerships, expansions, mergers & acquisitions, and others to gain a strong position in the industry.
About Us:
Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.